Pilot Study of the Entarik System With Advanced Functionality in Health Adults

Description

In this single-site study, data will be recorded during nasogastric or orogastric placement (and post-pyloric placement) and removal of the Entarik Feeding Tube. Data will also be collected prior to, during, and following the delivery of a meal through the feeding tube.

Conditions

Healthy Adults

Talk to us

Study Overview

On this page

Study Details

Study overview

In this single-site study, data will be recorded during nasogastric or orogastric placement (and post-pyloric placement) and removal of the Entarik Feeding Tube. Data will also be collected prior to, during, and following the delivery of a meal through the feeding tube.

Pilot Study of the Entarik System With Advanced Functionality in Health Adults

Pilot Study of the Entarik System With Advanced Functionality in Health Adults

Condition
Healthy Adults
Intervention / Treatment

-

Contacts and Locations

Berkeley

Gravitas Medical, Inc., Berkeley, California, United States, 94710

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. At least 18 years old
  • 2. Able to provide informed consent
  • 3. Capable and willing to follow all study-related procedures
  • 4. Confirmed fasted state for a minimum of 8 hours prior to study initiation
  • 1. Inability to receive a feeding tube
  • 2. Known self-reported history of hiatal hernia, esophagitis, esophageal strictures or gastric ulcers
  • 3. Has a basilar skull fracture
  • 4. Self-reports pregnancy
  • 5. Deemed unsuitable for enrollment in study by the investigator based on subjects' history or physical examination

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Gravitas Medical, Inc.,

Thomas Sorrentino, MD, PRINCIPAL_INVESTIGATOR,

Study Record Dates

2025-04-22